Flavor variety is an important component in young smokers’ decisions to switch to e-cigarettes, new research from Weill Cornell Medicine indicates. The investigators say their findings provide critical insight into what attracts teens to the products and may also help policymakers develop strategies to regulate e-cigarettes in a way that reduces teenage use without compromising a critical method for adults to quit or reduce cigarette smoking. Read More
Our director, Frank J. Chaloupka, was ranked among “some of the world’s most influential scientific minds” included on the 2015 Thomson Reuters Highly Cited Researchers list. Read More
In Perth for the Oceania Tobacco Control Conference 2015, Dr. Chaloupka was interviewed on Periscope by Marie McInerney of Croakey News. In the interview, they discuss current issues in the economics of tobacco control, including: Read More
New Zealand has been praised for its history of aggressive tobacco taxation, with a 10% increase in taxes on tobacco products every year since 2010 that has resulted in an overall average drop in cigarette sales of 23%. In light of the government's recent decision not to extend tobacco tax increases beyond 2016, Dr. Chaloupka was in New Zealand last week with a group of leading tobacco control experts to urge the government to reconsider. Read More
Dr. Frank Chaloupka is a distinguished professor of economics at the University of Illinois at Chicago and is an internationally respected scientist in the area of tobacco control. Read More
Amidst calls for the government of New Zealand to consider its next move on smoke-free policies, Dr. Chaloupka met with economics journalist Nadine Chalmers-Ross on New Zealand's national television broadcaster TVNZ. They discuss tobacco taxation, its impact on low-income populations, and other potential strategies to reduce smoking and improve health in New Zealand. Read More
It is time to rethink conventional wisdom on tobacco taxation, say Tobacconomics researchers in a new Perspective in the New England Journal of Medicine. For decades now, the evidence-based best practice has been to tax all tobacco products at similar levels since they all harm health. The rapid evolution of the nicotine-delivery product marketplace, however, has led researchers to reconsider. Read More
